Shares of Sanofi SA (ADR) (NYSE:SNY) ended Tuesday session in green amid volatile trading. The shares closed up +0.53 points or 1.34% at $40.16 with 1.97 million shares getting traded. Post opening the session at $40.27, the shares hit an intraday low of $40.11 and an intraday high of $40.33 and the price vacillated in this range throughout the day. The company has a market cap of $104.31 billion and the numbers of outstanding shares have been calculated to be 1.29 billion shares.
Sanofi SA (ADR) (SNY) declared recently that the first patient has been enrolled and received an infusion in a pivotal Phase 3 clinical trial named COMET for the investigational therapy neoGAA. NeoGAA is a second-generation enzyme replacement therapy being studied for the treatment of Pompe disease.
Pompe disease is a progressive, debilitating and often fatal neuromuscular disease caused by a genetic deficiency or dysfunction of the lysosomal enzyme acid alpha-glucosidase (GAA) affecting an estimated 50,000 people worldwide. Patients often lose their ability to walk and require wheelchairs to assist with mobility. They also often experience difficulty breathing and may require mechanical ventilation to breathe.
Shares of Express Scripts Holding Company (NASDAQ:ESRX) ended Tuesday session in red amid volatile trading. The shares closed down -0.53 points or -0.75% at $69.85 with 5.76 million shares getting traded. Post opening the session at $67.97, the shares hit an intraday low of $67.58 and an intraday high of $70.11 and the price vacillated in this range throughout the day. The company has a market cap of $43.40 billion and the numbers of outstanding shares have been calculated to be 616.62 million shares.
Express Scripts Holding Company (ESRX) operates as a pharmacy benefit administration (PBM) company in the United States, Canada, and Europe. The company operates through two segments, PBM and Other Business Operations. The companys PBM segments products and services include clinical solutions to enhance health outcomes; specialized pharmacy care; home delivery pharmacy; specialty pharmacy, counting the distribution of fertility pharmaceuticals that require special handling or packaging; and retail network pharmacy administration. It also provides benefit design consultation; drug utilization review; drug formulary administration; an array of Medicare, Medicaid, and health insurance marketplace; administration of a group purchasing organization; and consumer health and drug information services.